NTES · NASDAQ-GS
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $16.11B | $14.43B | $14.57B | $13.99B | $13.75B | $11.29B | $8.51B | $9.77B |
| Cost of Revenue | $5.75B | $5.41B | $5.69B | $6.34B | $6.38B | $5.32B | $3.98B | $5.64B |
| Gross Profit | $10.35B | $9.02B | $8.88B | $7.65B | $7.37B | $5.97B | $4.53B | $4.13B |
| Research & Development | $2.53B | $2.40B | $2.32B | $2.18B | $2.21B | $1.59B | $1.21B | $1.13B |
| Selling, General & Administrative | $604.62M | $623.43M | $690.13M | $680.83M | $669.04M | $516.75M | $449.64M | $464.19M |
| Operating Expenses | $5.23B | $4.96B | $4.98B | $4.80B | $4.79B | $3.75B | $2.55B | $2.98B |
| Operating Income | $5.12B | $4.05B | $3.90B | $2.85B | $2.58B | $2.23B | $1.98B | $1.15B |
| Other Income / (Expense) | $155.37M | $82.49M | $148.40M | $122.78M | $111.48M | $112.98M | $63.12M | $87.15M |
| Income Before Taxes | $5.84B | $4.89B | $4.80B | $3.52B | $3.31B | $2.36B | $2.35B | $1.30B |
| Provision for Income Taxes | $862.66M | $748.21M | $661.94M | $729.55M | $647.82M | $466.18M | $418.67M | $358.76M |
| Net Income | $4.98B | $4.15B | $4.13B | $2.88B | $2.66B | $1.89B | $3.08B | $942.10M |
| Basic EPS | $1.52 | $1.27 | $1.29 | $0.90 | $0.80 | $0.56 | $0.95 | $0.28 |
| Diluted EPS | $1.50 | $1.26 | $1.27 | $0.89 | $0.79 | $0.55 | $0.94 | $0.27 |
| Basic Shares Outstanding | 3.19B | 3.20B | 3.22B | 3.26B | 3.33B | 3.31B | 3.22B | 3.24B |
| Diluted Shares Outstanding | 3.22B | 3.23B | 3.25B | 3.30B | 3.37B | 3.35B | 3.25B | 3.25B |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $8.83 | $8.57 | $9.12 | 3 | ↑0 ↓0 |
| Dec 2027 | $9.81 | $9.29 | $10.30 | 3 | ↑0 ↓0 |
| Dec 2028 | $10.88 | $10.31 | $11.58 | 3 | ↑0 ↓0 |
| Dec 2029 | $11.27 | $11.27 | $11.27 | 1 | ↑0 ↓0 |